THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
Clinical trial NCT07446257 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07446257
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2029-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.